MASTER CLINICAL STUDY AGREEMENTStudy Agreement • December 16th, 2014 • Juno Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledDecember 16th, 2014 Company Industry JurisdictionThis Master Clinical Study Agreement is entered into as of November 21, 2013 (the “Effective Date”), by and between Memorial Sloan-Kettering Cancer Center (“MSKCC”), a New York nonprofit corporation, and Juno Therapeutics, Inc. (“Sponsor”), a Delaware corporation.